Cargando…
A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease?
This editorial examines what has caused the evidence around ivermectin to be so controversial, provides a brief analysis of recently published evidence, and highlights why it is important to learn lessons from ivermectin for future re-purposed drugs.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005062/ https://www.ncbi.nlm.nih.gov/pubmed/36915278 http://dx.doi.org/10.2217/fvl-2023-0006 |